Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran vs Rivaroxaban in Cerebral Venous Thrombosis
NCT06551402Phase 3Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Aug 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dabigatran etexilate oral solution in Cerebral venous thrombosis (CVT), sponsored by Kafrelsheikh University. Started Aug 2024; status: recruiting.
02
Drugs
dabigatran etexilate oral solution
03
Conditions
Cerebral venous thrombosis (CVT)
Beyond the preview
Go deeper on NCT06551402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06551402.